FDA
-
-
-
-
-
-
-
ResVita Bio adds dermatologist John Doux to board of directors
-
-
-
-
-
-
-
Palvella Therapeutics Named Healthcare & Life Sciences Company of the Year at the Philadelphia Alliance for Capital and Technologies (PACT) Ecosystem Awards
-
-
-
-
-
-
-
Palvella Therapeutics Announces Uplisting to the Nasdaq Global Market
-
-
-
-
-
-
-
Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026
-
-
-
-
-
-
-
Palvella publishes research on lymphatic malformation subtypes
-
-
-
-
-
-
-
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
-
-
-
-
-
-
-
Palvella Therapeutics raises $230 million in upsized stock offering
-
324,763 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

